Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue reduced its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 1.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 124,866 shares of the company’s stock after selling 2,360 shares during the quarter. State of Alaska Department of Revenue’s holdings in Bath & Body Works were worth $4,841,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of BBWI. UMB Bank n.a. boosted its holdings in Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after buying an additional 335 shares in the last quarter. True Wealth Design LLC increased its holdings in shares of Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after buying an additional 1,054 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after acquiring an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of Bath & Body Works during the 3rd quarter worth $39,000. Finally, Friedenthal Financial acquired a new position in shares of Bath & Body Works in the 4th quarter worth $57,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Price Performance

Shares of BBWI stock opened at $35.89 on Friday. The firm has a market cap of $7.77 billion, a P/E ratio of 8.75, a PEG ratio of 1.01 and a beta of 1.83. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The stock’s 50-day moving average is $37.75 and its two-hundred day moving average is $33.66.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm’s revenue was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.48 earnings per share. As a group, research analysts expect that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.23%. Bath & Body Works’s payout ratio is presently 19.51%.

Analysts Set New Price Targets

BBWI has been the subject of several analyst reports. Argus reaffirmed a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Morgan Stanley reduced their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. Barclays lifted their target price on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 26th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Finally, TD Cowen lifted their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Moderate Buy” and an average price target of $43.19.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.